Besides, cancer hallmarks consisting of “epithelial-mesenchymal transition” and “TGF-β signaling” were also significantly enriched in the high-risk group (Figures 5(b) and 5(c)), further confirming that ARS would be an effective tool in screening patients with poor prognosis from the functional perspective. The gene discussed is TGFB1; the disease is cancer.